As of April 30, 2024, Stelmine Canada Ltd. has 101.91M shares outstanding.
| Shares Outstanding | 101.91M |
These figures are as of April 30, 2024.
| PB Ratio | 1.31 |
| P/TBV Ratio | 0.53 |
| P/FCF Ratio | 1.68 |
| P/OCF Ratio | 5.81 |
These figures are as of April 30, 2024. Stelmine Canada Ltd. trades at an EV/FCF ratio of 1.77, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.
| EV / FCF | 1.77 |
As of April 30, 2024, Stelmine Canada Ltd. maintains a current ratio of 0.22, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.80, indicating moderate leverage, while an interest coverage ratio of -35.20 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.22 |
| Quick Ratio | -0.35 |
| Debt / Equity | 0.80 |
| Debt / EBITDA | -0.06 |
| Interest Coverage | -35.20 |
Over the twelve months ended April 30, 2024, Stelmine Canada Ltd. posted a negative return on equity (ROE) of -21.30, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -8.02, reflecting losses generated across the asset base.
| Return on Equity (ROE) | -21.30 |
| Return on Assets (ROA) | -8.02 |
These figures cover the twelve months ended April 30, 2024. Free cash flow yield stands at 59.38, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -22.48, meaning Stelmine Canada Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -22.48 |
| FCF Yield | 59.38 |
Stelmine Canada Ltd.'s most recent stock split took place on June 3, 2016 with a 10:1 split ratio.
| Last Split Date | 6/3/2016 |
| Split Ratio | 10:1 |
As of April 30, 2024, Stelmine Canada Ltd. has an Altman Z-Score of 2.61, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.61 |
Already premium?